Abbott Laboratories (ABT) Asset Writedowns and Impairment (2016)

Abbott Laboratories has disclosed Asset Writedowns and Impairment across 1 years of filings, most recently posting $947.0 million for Q3 2016.

• Asset Writedowns and Impairment for Q3 2016 came in at $947.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2016 was $947.0 million (changed N/A YoY), and the FY2016 annual result was $947.0 million, changed N/A from the prior year.
• Asset Writedowns and Impairment came in at $947.0 million for Q3 2016 at Abbott Laboratories.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $947.0 million in Q3 2016 to a low of $947.0 million in Q3 2016.